Max Robotics — Global Service Robot Directory + US Certification

About

Andrew Rowan is a leading figure in pandemic response and clinical diagnostics, with his most impactful work centered on developing scalable testing infrastructure during global health emergencies. His landmark 2020 study, "Scalable and Resilient SARS-CoV-2 testing in an Academic Centre," which has garnered 14 citations, provided a critical blueprint for rapidly expanding COVID-19 testing capacity within academic medical centers. This work addressed the acute shortage of tests that left healthcare workers vulnerable, demonstrating how to build resilient, high-throughput diagnostic pipelines under crisis conditions. Beyond this seminal paper, Rowan's research spans infectious disease epidemiology, laboratory medicine, and health systems resilience. His contributions have been instrumental in shaping institutional preparedness strategies, ensuring that academic centers can pivot quickly to meet surge demands during outbreaks. By combining operational research with real-world implementation, Rowan has helped bridge the gap between theoretical pandemic planning and practical, life-saving action. His work remains a cornerstone for institutions seeking to build robust, adaptable testing frameworks that can withstand future biological threats.